Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

2.

Sleepiness and sleep-related accidents in commercial bus drivers.

Vennelle M, Engleman HM, Douglas NJ.

Sleep Breath. 2010 Feb;14(1):39-42. doi: 10.1007/s11325-009-0277-z. Epub 2009 Jul 9.

PMID:
19588178
3.

Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer.

Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J.

J Clin Oncol. 2008 Oct 1;26(28):4651-8. doi: 10.1200/JCO.2007.13.9006. Epub 2008 Jun 30. Erratum in: J Clin Oncol. 2010 Jul 1;28(19):3205.

PMID:
18591549
4.

Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice.

Espie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P.

Sleep. 2007 May;30(5):574-84.

PMID:
17552372
5.

Comparison of CPAP titration at home or the sleep laboratory in the sleep apnea hypopnea syndrome.

Cross MD, Vennelle M, Engleman HM, White S, Mackay TW, Twaddle S, Douglas NJ.

Sleep. 2006 Nov;29(11):1451-5.

PMID:
17162992
6.

Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure.

Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ.

J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1143-9. Epub 2006 Jun 13.

7.

Sleep, driving and the workplace.

Engleman HM, Douglas NJ.

Clin Med (Lond). 2005 Mar-Apr;5(2):113-7. Review. No abstract available.

8.

Clinical audit of subjects with snoring & sleep apnoea/hypopnoea syndrome fitted with mandibular repositioning splint.

Izci B, McDonald JP, Coleman EL, Mackay TW, Douglas NJ, Engleman HM.

Respir Med. 2005 Mar;99(3):337-46.

9.

Can psychological factors help us to determine adherence to CPAP? A prospective study.

Wild MR, Engleman HM, Douglas NJ, Espie CA.

Eur Respir J. 2004 Sep;24(3):461-5.

10.
11.

Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS).

Engleman HM, Wild MR.

Sleep Med Rev. 2003 Feb;7(1):81-99. Review.

PMID:
12586532
12.

Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint.

Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, Mackay TW, Douglas NJ.

Am J Respir Crit Care Med. 2002 Sep 15;166(6):855-9.

PMID:
12231497
13.

When does 'mild' obstructive sleep apnea/hypopnea syndrome merit continuous positive airway pressure treatment?

Engleman HM.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):743-5. No abstract available.

PMID:
11897636
14.

Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy.

McFadyen TA, Espie CA, McArdle N, Douglas NJ, Engleman HM.

Eur Respir J. 2001 Dec;18(6):996-1002.

15.

The science of designing ethical CPAP trials.

Douglas NJ, Engleman HM, Faccenda JF, McArdle N.

Am J Respir Crit Care Med. 2002 Jan 1;165(1):132-4. No abstract available.

PMID:
11779744
16.

Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life.

McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ.

Thorax. 2001 Jul;56(7):513-8.

17.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.

Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ.

Am J Respir Crit Care Med. 2001 Mar;163(4):918-23.

PMID:
11282766
18.

Effects of CPAP on vigilance and related functions in patients with the sleep apnea/hypopnea syndrome.

Douglas NJ, Engleman HM.

Sleep. 2000 Jun 15;23 Suppl 4:S147-9. Review.

PMID:
10893090
19.

Cognitive function in the sleep apnea/hypopnea syndrome (SAHS).

Engleman HM, Kingshott RN, Martin SE, Douglas NJ.

Sleep. 2000 Jun 15;23 Suppl 4:S102-8. Review.

PMID:
10893080
20.

Predictors of improvements in daytime function outcomes with CPAP therapy.

Kingshott RN, Vennelle M, Hoy CJ, Engleman HM, Deary IJ, Douglas NJ.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):866-71.

PMID:
10712335
21.

Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome.

McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ.

Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1108-14.

PMID:
10194153
22.

Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?

Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ.

Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1096-100.

PMID:
10194151
23.

CPAP therapy: outcomes and patient use.

Douglas NJ, Engleman HM.

Thorax. 1998 Oct;53 Suppl 3:S47-8. Review. No abstract available.

24.

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome.

Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ.

Am J Respir Crit Care Med. 1999 Feb;159(2):461-7.

PMID:
9927358
25.

Does arousal frequency predict daytime function?

Kingshott RN, Engleman HM, Deary IJ, Douglas NJ.

Eur Respir J. 1998 Dec;12(6):1264-70.

26.
27.

Microarousals in patients with sleep apnoea/hypopnoea syndrome.

Martin SE, Engleman HM, Kingshott RN, Douglas NJ.

J Sleep Res. 1997 Dec;6(4):276-80.

28.
29.

Obstructive sleep apnoea. Some criticisms of studies are unfounded.

Engleman HM, Martin SE, Deary IJ, Douglas NJ.

BMJ. 1997 Aug 9;315(7104):369. No abstract available.

30.

Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome.

Engleman HM, Martin SE, Deary IJ, Douglas NJ.

Thorax. 1997 Feb;52(2):114-9.

31.

Inhaled salmeterol or oral theophylline in nocturnal asthma?

Selby C, Engleman HM, Fitzpatrick MF, Sime PM, Mackay TW, Douglas NJ.

Am J Respir Crit Care Med. 1997 Jan;155(1):104-8.

PMID:
9001297
32.

Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers".

Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ.

Sleep. 1996 Jun;19(5):378-81.

PMID:
8843528
33.

Self-reported use of CPAP and benefits of CPAP therapy: a patient survey.

Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ.

Chest. 1996 Jun;109(6):1470-6.

PMID:
8769496
34.

The effect of sleep fragmentation on daytime function.

Martin SE, Engleman HM, Deary IJ, Douglas NJ.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1328-32.

PMID:
8616562
35.

Self assessment of daytime sleepiness: patient versus partner.

Kingshott RN, Sime PJ, Engleman HM, Douglas NJ.

Thorax. 1995 Sep;50(9):994-5.

36.

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.

Engleman HM, Martin SE, Deary IJ, Douglas NJ.

Lancet. 1994 Mar 5;343(8897):572-5.

PMID:
7906330
37.

Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome.

Engleman HM, Martin SE, Douglas NJ.

Thorax. 1994 Mar;49(3):263-6.

38.

Cognitive effects and daytime sleepiness.

Engleman HM, Douglas NJ.

Sleep. 1993 Dec;16(8 Suppl):S79. No abstract available.

PMID:
8178036
39.

CPAP compliance.

Engleman HM, Douglas NJ.

Sleep. 1993 Dec;16(8 Suppl):S114. No abstract available.

PMID:
8177996
40.
41.

Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects.

Fitzpatrick MF, Engleman HM, Boellert F, McHardy R, Shapiro CM, Deary IJ, Douglas NJ.

Am Rev Respir Dis. 1992 Jun;145(6):1355-8.

PMID:
1596003
42.

Magnetic resonance imaging of the brain in alcoholics: cerebral atrophy, lifetime alcohol consumption, and cognitive deficits.

Chick JD, Smith MA, Engleman HM, Kean DM, Mander AJ, Douglas RH, Best JJ.

Alcohol Clin Exp Res. 1989 Aug;13(4):512-8.

PMID:
2679207
43.

Cerebrospinal fluid pressure in pyogenic meningitis.

Minns RA, Engleman HM, Stirling H.

Arch Dis Child. 1989 Jun;64(6):814-20.

44.

The use of CSF pressure recordings in acute purulent meningitis.

Minns RA, Engleman HM.

Z Kinderchir. 1988 Dec;43 Suppl 2:28-9.

PMID:
3145660
45.

Magnetic resonance imaging in pre-senile dementia of the Alzheimer-type, multi-infarct dementia and Korsakoff's syndrome.

Christie JE, Kean DM, Douglas RH, Engleman HM, St Clair D, Blackburn IM.

Psychol Med. 1988 May;18(2):319-29.

PMID:
3399584
46.

Brain hydration during alcohol withdrawal in alcoholics measured by magnetic resonance imaging.

Smith MA, Chick JD, Engleman HM, Kean DM, Mander AJ, Douglas RH, Best JJ.

Drug Alcohol Depend. 1988 Feb;21(1):25-8.

PMID:
3366051
47.

CSF production rate: "real time" estimation.

Minns RA, Brown JK, Engleman HM.

Z Kinderchir. 1987 Dec;42 Suppl 1:36-40.

PMID:
3433972

Supplemental Content

Loading ...
Support Center